The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Pulmonary artery hypertension: an underrated disease manifestation in cystic fibrosis?
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several diseases that share both disproportionately high rates of vascular disease and PH, including Sjögren's and systemic sclerosis, HIV, and cystic fibrosis, also feature dysregulated salivary flow and altered oral microbial populations.
“Significantly, several diseases that share both disproportionately high rates of vascular disease and PH, including Sjögren's and systemic sclerosis[294–297], HIV[7,11], and cystic fibrosis[298] also feature dysregulated salivary flow[299–302] and altered oral microbial populations[224,303–306].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [298]
Citations
Cites
Webb, A. K. (2006) · Cited by 4,369
Ratjen, F. A., Bell, S. C., Rowe, S. M., Goss, C. H., Quittner, A. L., & Bush, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.10 · Cited by 575
Self-citationPulmonary Arterial Enlargement and Acute Exacerbations of COPD
Wells, J. M., Washko, G. R., Han, M. K., Abbas, N., Nath, H. P., Mamary, A. J., Regan, E. A., Bailey, W. C., Martínez, F. J., Westfall, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203830 · Cited by 502
Iyer, A. S., Wells, J. M., Vishin, S., Bhatt, S. P., Wille, K. M., & Dransfield, M. T. (2013) · CHEST Journal · doi:10.1378/chest.13-1422 · Cited by 191
Pulmonary hypertension in cystic fibrosis with advanced lung disease
Hayes, D., Tobias, J. D., Mansour, H. M., Kirkby, S., McCoy, K. S., Daniels, C. J., & Whitson, B. A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1382oc · Cited by 77
Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival
Tonelli, A. R., Fernández-Bussy, S., Lodhi, S., Akindipe, O., Carrie, R. D., Hamilton, K. K., Mubarak, K. K., & Baz, M. A. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.04.006 · Cited by 50
Main Pulmonary Artery–to–Ascending Aorta Diameter Ratio in Healthy Children on MDCT
Compton, G. L., Florence, J., MacDonald, C., Yoo, S., Humpl, T., & Manson, D. E. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.15.14301 · Cited by 36
Hayes, D., Higgins, R. S., Kirkby, S., McCoy, K. S., Wehr, A. M., Lehman, A. M., & Whitson, B. A. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.12.004 · Cited by 35
Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study
Wells, J. M., Farris, R. F., Gosdin, T. A., Dransfield, M. T., Wood, M., Bell, S. C., & Rowe, S. M. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30105-9 · Cited by 30
Simanovsky, N., Gileles‐Hillel, A., Frenkel, R., Shosayov, D., & Hiller, N. (2013) · Journal of Thoracic Imaging · doi:10.1097/rti.0b013e3182956be2 · Cited by 3
Flagged first, then by citations
Cited by
Sorted by citations
Koch, C. D., Gladwin, M. T., Freeman, B. A., Lundberg, J. O., Weitzberg, E., & Morris, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.015 · Cited by 186
Pulmonary hypertension associated with lung diseases
Shlobin, O. A., Adir, Y., Barberà, J. A., Cottin, V., Harari, S. A., Jutant, E., Pepke‐Żaba, J., Ghofrani, H. A., & Channick, R. N. (2024) · European Respiratory Journal · doi:10.1183/13993003.01200-2024 · Cited by 159
Cardiovascular complications in cystic fibrosis: A review of the literature
Poore, T. S., Taylor‐Cousar, J. L., & Zemanick, E. T. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.04.016 · Cited by 67
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension
Ribeuz, H. L., To, L., Ghigna, M., Martin, C., Nagaraj, C., Dréano, E., Rücker‐Martin, C., Girerd, B., Bouligand, J., Péchoux, C., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00653-2020 · Cited by 34
Vermaut, A., Aerts, G., Willems, L., Geudens, V., Hooft, C., Kerckhof, P., Vanvuchelen, L., Zapata‐Ortega, M., Beeckmans, H., Jin, X., et al. (2025) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2025.04.002 · Cited by 3
Ghaderian, M., Keivanfar, M., Beiranvand, S. B., & Reisi, M. (2019) · International journal of pediatrics · doi:10.22038/ijp.2019.41556.3502 · Cited by 2
Proinflammatory indicators and the relevance of echocardiography in children with cystic fibrosis
Yağcı, Ö. Ö., Sülü, A., Köşger, P., Yildirim, G. K., Anıl, H., Uçar, B., & Harmancı, K. (2023) · Cardiology in the Young · doi:10.1017/s1047951123001178
Mechanisms underlying the roles of leukocytes in the progression of cystic fibrosis
Asare, P. F., Jayapal, M., Tai, A., Maiolo, S., Chapman, S. A., Morton, J. M., Hopkins, E., Reynolds, P. N., Hodge, S. J., & Tran, H. B. (2024) · Experimental Lung Research · doi:10.1080/01902148.2024.2424201
Pulmonary Vascular Disease Associated with Other Parenchymal Lung Diseases
Louw, E. H., van Heerden, J. K., Buckley, A., & Allwood, B. (2025) · Respiratory medicine · doi:10.1007/978-3-032-03581-3_12
Metadata
- Authors
- Ratjen, F.
- Affiliations
- Hospital for Sick Children (CA)
- Corresponding author
- Ratjen, Felix
- ORCID
- Ratjen, Felix
- Venue
- The Lancet Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 4
- Issue
- 8
- Pages
- 596-598
- ISSN
- 2213-2600 (ISSN-L)
- OpenAlex
- W2414786176
- Cited by
- 9
- References
- 10
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 1 · 2021: 2 · 2019: 1 · 2016: 1
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Lancet Respiratory Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- pulmonary arterial hypertension, cystic fibrosis, lung injury, airway obstruction, comorbidities, incidence
- MeSH terms
- Cystic Fibrosis, Humans, Hypertension, Hypertension, Pulmonary, Pulmonary Artery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
